List of Tables
Table 1. Global Gene Therapy on Neurological Diseases Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Viral Gene Therapy
Table 3. Key Players of Non-viral Gene Therapy
Table 4. Global Gene Therapy on Neurological Diseases Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Gene Therapy on Neurological Diseases Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Gene Therapy on Neurological Diseases Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Gene Therapy on Neurological Diseases Market Share by Region (2020-2025)
Table 8. Global Gene Therapy on Neurological Diseases Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Gene Therapy on Neurological Diseases Market Share by Region (2026-2031)
Table 10. Gene Therapy on Neurological Diseases Market Trends
Table 11. Gene Therapy on Neurological Diseases Market Drivers
Table 12. Gene Therapy on Neurological Diseases Market Challenges
Table 13. Gene Therapy on Neurological Diseases Market Restraints
Table 14. Global Gene Therapy on Neurological Diseases Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Gene Therapy on Neurological Diseases Market Share by Players (2020-2025)
Table 16. Global Top Gene Therapy on Neurological Diseases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy on Neurological Diseases as of 2024)
Table 17. Ranking of Global Top Gene Therapy on Neurological Diseases Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Gene Therapy on Neurological Diseases Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Gene Therapy on Neurological Diseases, Headquarters and Area Served
Table 20. Global Key Players of Gene Therapy on Neurological Diseases, Product and Application
Table 21. Global Key Players of Gene Therapy on Neurological Diseases, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Gene Therapy on Neurological Diseases Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Gene Therapy on Neurological Diseases Revenue Market Share by Type (2020-2025)
Table 25. Global Gene Therapy on Neurological Diseases Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Gene Therapy on Neurological Diseases Revenue Market Share by Type (2026-2031)
Table 27. Global Gene Therapy on Neurological Diseases Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Gene Therapy on Neurological Diseases Revenue Market Share by Application (2020-2025)
Table 29. Global Gene Therapy on Neurological Diseases Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Gene Therapy on Neurological Diseases Revenue Market Share by Application (2026-2031)
Table 31. North America Gene Therapy on Neurological Diseases Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Gene Therapy on Neurological Diseases Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Gene Therapy on Neurological Diseases Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Gene Therapy on Neurological Diseases Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Gene Therapy on Neurological Diseases Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Gene Therapy on Neurological Diseases Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Gene Therapy on Neurological Diseases Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Gene Therapy on Neurological Diseases Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Gene Therapy on Neurological Diseases Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Gene Therapy on Neurological Diseases Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Gene Therapy on Neurological Diseases Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Gene Therapy on Neurological Diseases Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Gene Therapy on Neurological Diseases Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Gene Therapy on Neurological Diseases Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Gene Therapy on Neurological Diseases Market Size by Country (2026-2031) & (US$ Million)
Table 46. Biogen Company Details
Table 47. Biogen Business Overview
Table 48. Biogen Gene Therapy on Neurological Diseases Product
Table 49. Biogen Revenue in Gene Therapy on Neurological Diseases Business (2020-2025) & (US$ Million)
Table 50. Biogen Recent Development
Table 51. Novartis Company Details
Table 52. Novartis Business Overview
Table 53. Novartis Gene Therapy on Neurological Diseases Product
Table 54. Novartis Revenue in Gene Therapy on Neurological Diseases Business (2020-2025) & (US$ Million)
Table 55. Novartis Recent Development
Table 56. Sarepta Therapeutics Company Details
Table 57. Sarepta Therapeutics Business Overview
Table 58. Sarepta Therapeutics Gene Therapy on Neurological Diseases Product
Table 59. Sarepta Therapeutics Revenue in Gene Therapy on Neurological Diseases Business (2020-2025) & (US$ Million)
Table 60. Sarepta Therapeutics Recent Development
Table 61. Research Programs/Design for This Report
Table 62. Key Data Information from Secondary Sources
Table 63. Key Data Information from Primary Sources
Table 64. Authors List of This Report
List of Figures
Figure 1. Gene Therapy on Neurological Diseases Picture
Figure 2. Global Gene Therapy on Neurological Diseases Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Gene Therapy on Neurological Diseases Market Share by Type: 2024 VS 2031
Figure 4. Viral Gene Therapy Features
Figure 5. Non-viral Gene Therapy Features
Figure 6. Global Gene Therapy on Neurological Diseases Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Gene Therapy on Neurological Diseases Market Share by Application: 2024 VS 2031
Figure 8. Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Other Case Studies
Figure 11. Gene Therapy on Neurological Diseases Report Years Considered
Figure 12. Global Gene Therapy on Neurological Diseases Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Gene Therapy on Neurological Diseases Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Gene Therapy on Neurological Diseases Market Share by Region: 2024 VS 2031
Figure 15. Global Gene Therapy on Neurological Diseases Market Share by Players in 2024
Figure 16. Global Top Gene Therapy on Neurological Diseases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy on Neurological Diseases as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Gene Therapy on Neurological Diseases Revenue in 2024
Figure 18. North America Gene Therapy on Neurological Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Gene Therapy on Neurological Diseases Market Share by Country (2020-2031)
Figure 20. United States Gene Therapy on Neurological Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Gene Therapy on Neurological Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Gene Therapy on Neurological Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Gene Therapy on Neurological Diseases Market Share by Country (2020-2031)
Figure 24. Germany Gene Therapy on Neurological Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Gene Therapy on Neurological Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Gene Therapy on Neurological Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Gene Therapy on Neurological Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Gene Therapy on Neurological Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Gene Therapy on Neurological Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Gene Therapy on Neurological Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Gene Therapy on Neurological Diseases Market Share by Region (2020-2031)
Figure 32. China Gene Therapy on Neurological Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Gene Therapy on Neurological Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Gene Therapy on Neurological Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Gene Therapy on Neurological Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Gene Therapy on Neurological Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Gene Therapy on Neurological Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Gene Therapy on Neurological Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Gene Therapy on Neurological Diseases Market Share by Country (2020-2031)
Figure 40. Mexico Gene Therapy on Neurological Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Gene Therapy on Neurological Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Gene Therapy on Neurological Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Gene Therapy on Neurological Diseases Market Share by Country (2020-2031)
Figure 44. Turkey Gene Therapy on Neurological Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Gene Therapy on Neurological Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Gene Therapy on Neurological Diseases Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Biogen Revenue Growth Rate in Gene Therapy on Neurological Diseases Business (2020-2025)
Figure 48. Novartis Revenue Growth Rate in Gene Therapy on Neurological Diseases Business (2020-2025)
Figure 49. Sarepta Therapeutics Revenue Growth Rate in Gene Therapy on Neurological Diseases Business (2020-2025)
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
